Cancellation of state registration. BICHALUTAMIDE GRINDEX

April 10, 2018
Active substances:
ICD-10:
II.C60-C63.C61    Malignant neoplasm of prostate
Bicalutamide, prostate cancer, malignant neoplasm of prostate, prostate, prostate cancer

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state registermedicinal products for medical use of medicinal product (registration certificate LP-001398 dated 28.12.2011 issued by JSC "Grindeks", Latvia):

BIKALUTAMIDE GRINDEKC (trade name of the medicinal product)

Bicalutamide (international non-proprietary or grouping or chemical name)

film coated tablets, 50 mg (dosage form, dosage)

JSC "Grindeks", Latvia Krustpils St. 53, Riga, LV-1057, Latvia (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by an authorized legal entity of JSC "Grindeks", an application for the cancellation of the state registration of a medicinal product.